Advertisement

Topics

Phadia AB Company Profile

05:06 EST 19th December 2018 | BioPortfolio

Phadia develops, manufactures and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases.
Besides strategic management, administration and business development, the international center in Uppsala incorporates extensive research and development facilities, a state-of-the-art production plant and a robotized cold-store and distribution system operating cost-effectively around the clock. In Freiburg, Germany, a second center develops and supports diagnostic tests for autoimmune diseases.

Some 98 percent of production is exported to more than 3000 laboratories in 60 countries. Supplying seven out of ten allergy laboratory tests worldwide, the company has remained the world leader in its field for more than 25 years.

Around 500 people are employed at Phadia in Uppsala and Freiburg. Around 600 people work for the company's own sales and support subsidiaries in 18 countries around the world.

Location

P.O. Box 6460
UPPSALA
SE-751 37
Sweden

Contact

Phone: 46 18 16 50 00
Fax: 46 18 14 03 58
Email: marketing@phadia.com


News Articles [1 Associated News Articles listed on BioPortfolio]

EU OKs Thermo Fisher's allergy, autoimmune testing instrument

European regulators have given Thermo Fisher Scientific CE mark approval for a benchtop instrument called Phadia 200, designe -More- 

Drugs and Medications [0 Results]

None

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Diagnostic cut-off of A.fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis.

A.fumigatus-specific IgG is pivotal in making the diagnosis of chronic pulmonary aspergillosis (CPA). However, the cut-off value for A.fumigatus-specific IgG remains unknown. We included consecutive t...

The clinical significance of borderline results of the Elia CTD Screen assay.

Background Data on the clinical relevance of borderline results of solid-phase assays in the screening for antinuclear antibodies (ANA) are sparse. This study aimed to determine the clinical significa...

Positivity rates of in vitro inhalant/respiratory and food allergy tests in the northern midwestern United States.

Rates of allergy-test positivity vary by country and by regions within countries. Several studies have looked at allergy test results to determine the most common allergens. Many of these studies have...

Glycation of whey protein with dextrans of different molar mass: Effect on immunoglobulin E-binding capacity with blood sera obtained from patients with cow milk protein allergy.

A growing concern around the world is the number of people who are suffering from food protein allergies. One potential approach to decrease protein allergenicity is to block IgE-binding epitopes of t...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Evaluation and Validation of Novel Diagnostic Tool for Allergists (AbioSCOPE)

In this study, investigators evaluated for the first time the diagnostic efficacy of abioSCOPE® versus Phadia Laboratory System as an aid in the diagnosis of allergic diseases. Investigat...

Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease

The investigators will perform prospective observational multicenter study which includes children with suspicion of CD who referred to gastroscopy and intestinal biopsies (study group) an...

Companies [4 Associated Companies listed on BioPortfolio]

Phadia

Phadia is setting the standard as the global leader in allergy and autoimmune blood testing. The ImmunoCAP® Specific IgE blood test delivers Results You Can Trust. The accuracy...

Phadia AB

Phadia develops, manufactures and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. Besides strategic management, adminis...

Athera Biotechnologies AB

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two b...

Athera Biotechnologies & ALPCO

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two b...

More Information about "Phadia AB" on BioPortfolio

We have published hundreds of Phadia AB news stories on BioPortfolio along with dozens of Phadia AB Clinical Trials and PubMed Articles about Phadia AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phadia AB Companies in our database. You can also find out about relevant Phadia AB Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record